Beta Bionics chief commercial officer Mark Hopman sells 370 shares for $7,015.20
BBNX•Mark Hopman sold 370 Beta Bionics common shares on Oct. 1, 2026, at a weighted average price of $18.96, leaving him with 56,109 shares.
1. Share sale
Beta Bionics Chief Commercial Officer Mark Hopman sold 370 common shares on Oct. 1, 2026, for $7,015.20. The shares sold at a weighted average price of $18.96, within a range of $18.96 to $19.9599; his holdings fell to 56,109 shares.
